Skip to main content
Journal cover image

Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art.

Publication ,  Journal Article
Dinani, AM; Kowdley, KV; Noureddin, M
Published in: Hepatology
October 2021

The diagnosis of nonalcoholic fatty liver disease and associated fibrosis is challenging given the lack of signs, symptoms and nonexistent diagnostic test. Furthermore, follow up and treatment decisions become complicated with a lack of a simple reproducible method to follow these patients longitudinally. Liver biopsy is the current standard to detect, risk stratify and monitor individuals with nonalcoholic fatty liver disease. However, this method is an unrealistic option in a population that affects about one in three to four individuals worldwide. There is an urgency to develop innovative methods to facilitate management at key points in an individual's journey with nonalcoholic fatty liver disease fibrosis. Artificial intelligence is an exciting field that has the potential to achieve this. In this review, we highlight applications of artificial intelligence by leveraging our current knowledge of nonalcoholic fatty liver disease to diagnose and risk stratify NASH phenotypes.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Hepatology

DOI

EISSN

1527-3350

Publication Date

October 2021

Volume

74

Issue

4

Start / End Page

2233 / 2240

Location

United States

Related Subject Headings

  • Risk Assessment
  • Non-alcoholic Fatty Liver Disease
  • Neural Networks, Computer
  • Liver Cirrhosis
  • Humans
  • Gastroenterology & Hepatology
  • Diagnostic Techniques, Digestive System
  • Artificial Intelligence
  • 3204 Immunology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dinani, A. M., Kowdley, K. V., & Noureddin, M. (2021). Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art. Hepatology, 74(4), 2233–2240. https://doi.org/10.1002/hep.31869
Dinani, Amreen M., Kris V. Kowdley, and Mazen Noureddin. “Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art.Hepatology 74, no. 4 (October 2021): 2233–40. https://doi.org/10.1002/hep.31869.
Dinani, Amreen M., et al. “Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art.Hepatology, vol. 74, no. 4, Oct. 2021, pp. 2233–40. Pubmed, doi:10.1002/hep.31869.
Journal cover image

Published In

Hepatology

DOI

EISSN

1527-3350

Publication Date

October 2021

Volume

74

Issue

4

Start / End Page

2233 / 2240

Location

United States

Related Subject Headings

  • Risk Assessment
  • Non-alcoholic Fatty Liver Disease
  • Neural Networks, Computer
  • Liver Cirrhosis
  • Humans
  • Gastroenterology & Hepatology
  • Diagnostic Techniques, Digestive System
  • Artificial Intelligence
  • 3204 Immunology
  • 3202 Clinical sciences